Glioma presents one of the most malignant brain tumors, and the therapeutic effect is often limited due to the existence of brain tumor barrier. 1.98, 1.91 and 1.53-fold over that of NP-PTX group after 0.5, 1 and 4?h, respectively. Pep-NP-PTX could improve the anti-glioma efficacy with a median survival time of 32 days, which was… Continue reading Glioma presents one of the most malignant brain tumors, and the